Our faculty work daily in our clinics, research laboratories, and classrooms to fulfill our tripartite mission. All of them play an integral role in advancing medicine at Michigan, and all have different reasons for coming to Michigan and choosing their current path.
In an effort to share their stories, we are compiling this growing repository of Department of Internal Medicine faculty profiles.
Dr. Malani's research interests include infections in older adults, antimicrobial resistant organisms, and infection control. Dr. Malani also holds a long-standing interest in Humanities and Medicine. Her previous work has primarily centered on topics related to infection control, device associated infections, antimicrobial resistance, and infections in transplantation. She serves as an Associate Editor at the Journal of the American Medical Association (JAMA). Previously, she was an Associate Editor for Infection Control and Hospital Epidemiology and Deputy Editor at Clinical Infectious Diseases.
Well-known for being the first physician-researcher in the United States to describe carmine allergy/anaphylaxis, Dr. Baldwin - former training program director of the Allergy and Clinical Immunology Training Program - enjoys an international reputation for his research in this area. A member of the U-M faculty since 1994, he is a professor and division chief in the Division of Allergy and Clinical Immunology within the Department of Internal Medicine, and is board-certified in allergy and clinical immunology.
Dr. Baldwin has worked with the Food and Drug Administration to change labeling regulations, which now require carmine to be labeled by name on food labels (previously, it could be added to foods with nebulous descriptors such as “color added”). He has broad clinical interests, including allergic rhinitis, anaphylaxis, angioedema, asthma, drug allergies, urticaria, immune deficiencies, and aspirin exacerbated respiratory disease.
Dr. Mody is Professor with Tenure at the University of Michigan and Associate Director for Clinical Programs at the VA Ann Arbor GRECC. She has an active translational research laboratory to define the clinical and molecular epidemiology of antimicrobial resistant pathogens and developing measures to prevent them. Dr. Mody’s work has led to a thriving consortium of long-term care facilities in SE Michigan interested in learning ways to enhance infection prevention in a traditionally resource-poor setting. Her research is funded and supported by the NIH, the VA, and other foundations. Her most recent research projects involve two NIA funded RO1 studies to evaluate transmission of emerging resistant organisms in NHs and a multi-component targeted programs to curb infections in older skilled nursing home patients. She is also involved in an AHRQ funded grant to evaluate the usefulness of gown and glove use in nursing homes. She is nationally active at several career development and research dissemination activities at the American Geriatrics Society, Society for Healthcare Epidemiology of America, the Infectious Diseases Society of America, and the Joint Commission.
Dr. Gay's clinical and research interests include exercise physiology, pathophysiology of interstitial lung disease, and outcomes in chronic obstructive pulmonary disease. He is a member of the American Thoracic Society and the European Respiratory Society. He is a member of the FDA Advisory Committee on Pulmonary and Allergy Medications. Since joining the U-M faculty in 2000, Dr. Gay has been actively engaged in the Medical School Admissions Program, where he serves on the Admissions Committee, its Executive Committee, and the K30 Executive Curriculum Committee.
Dr. Kraftson's clinical and research interests are in general endocrinology, but also specifically focused in the area of obesity. He is a co-investigator in the Investigational Weight Management Program, as well as the co-director of the MEND Post-Bariatric Surgery Clinic. In addition to these interests, Dr. Kraftson is actively involved in educational pursuits involving medical students, residents, and fellows.
Dr. Flanders’ research and policy work focuses on the areas of quality improvement and patient safety. His research interests include hospitalists, hospital-acquired conditions and their prevention, dissemination of patient safety and quality improvement practices, and the diagnosis and treatment of lower respiratory infections, including community- and health care-acquired pneumonias. Dr. Flanders helped develop and now leads the Michigan Hospital Medicine Safety (HMS) consortium, a hospitalist-focused quality collaborative focused on preventing adverse events in hospitalized patients.